Industry News

Featuring news on life sciences, pharma, medical device, biotech, healthcare and healthcare IT companies:

Strategic transactions and financings
Launches of products, technology or services
Progress regarding research and development
General compamy exposure

"Industry News" is a paid service. For specifics, program options, and pricing, click here.

2 days ago
1 min

Early-stage DeepSight Technology closes on $25 million to reinvent diagnostic imaging

DeepSight Technology provides a platform to enhance non-invasive and invasive medical imaging for multiple diagnostic procedures.

3 days ago
3 min

Contract Research Organization Sai Life Sciences expands capabilities and funding

Sai Life Sciences is a CRO-CDMO that enables pharma and biotech companies to accelerate the discovery and development of small molecules.

4 days ago
3 min

Merck Global Health Innovation fund makes strategic investment in Octave Bioscience

Octave Bioscience was founded to deliver an end-to-end care management platform for multiple sclerosis and neurodegenertive diseases.

6 days ago
3 min

Revance Therapeutics (Nasdaq: RVNC) launches cloud-based OPUL for asthetic practices

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings.

Oct 10
2 min

GenEdit provides update on financing and research for its polymer nanoparticles

Our NanoGalaxy platform of non-viral, non-lipid polymer nanoparticles will enable opportunities to launch genetic medicines.

Oct 9
2 min

Amplo Biotechnology closes on round to advance gene therapies for neuromuscular junction disorders

"We see the potential to treat many neuromuscular diseases with a single gene therapy."

Oct 8
2 min

Startup Tuune wraps up $4.6 million to advance personalized birth control

Tuune intends to improve the healthcare experience for women, starting with more informed birth control choices.

Oct 6
4 min

NanoViricides (NYSE: NNVC) provides update of its Pan-Coronavirus COVID-19 drug development program

"Oral NV-CoV-2 should enable highly effective treatments for pediatric use, an urgent medical need that remains unmet..."

Oct 5
2 min

Virica Biotech closes on financing to expand its solutions for scaling of viral medicines

Most of the new treatments for fighting cancer, rare diseases, and infections are made possible because of advances in viral medicines.

Oct 4
4 min

Hemanext closes another equity round to improve the quality of red blood cells

The processing and storage of blood for transfusion is fundamental to healthcare, and over 90 million units of are transfused annually.

Oct 3
2 min

Elbit Systems (NASDAQ: ESLT) spin off Beyeonics closes on $36 million for operating room systems

Beyeonics technology aims to establish a new visualization and control standard in operating rooms using augmented reality.

Oct 2
2 min

Biotech Medicortex Finland Oy completes pre-IPO funding to advance diagnostic tests for brain injury

The proceeds of a net half million euro from the round will advance the development of company’s lead product candidate.

Oct 1
3 min

MIT biotech spinoff Kytopen raises $30 million to advance scalable technology for cell therapies

The funding will accelerate the commercialization of Kytopen’s high-throughput automated platform which links discovery to manufacturing.

Sep 30
3 min

AI-driven biotech company Envisagenics closes on Series-A financing for RNA drug discovery platform

Envisagenics' R&D focuses on diseases that are caused in part by RNA splicing deregulation and have patient populations with unmet needs.

Sep 28
2 min

Korea's CGBIO and NDR Medical Technology to collaborate on AI and medical imaging for surgeons

By providing reliable and accurate medical services to patients, CGBIO counts on stronger business competitiveness in digital healthcare.

Sep 25
3 min

UK Aspire Pharma acquired hy H.I.G. Capital

Aspire licenses and develops niche generic and specialty pharmaceutical products that offer innovative formulations.

Sep 24
3 min

Garuda Therapeutics raises $72 million Series A for its blood stem cell platform to cure diseases

Garuda is developing an off-the-shelf hematopoietic stem cell platform that will eliminate dependency on donor or patient cells.

Sep 21
2 min

myCaribou platform is launched to revolutionize medical device supply chains globally

The myCaribou platform enables manufacturers and distributors to connect tens of thousands of partners to drive sales globally.

Sep 20
3 min

Alkido Pharma (Nasdaq: AIKI) acquires interest in the tele-health company, Kerna Health

Kerna Health's platform gathers daily readings securely transmitted by devices used by patients, at home, in long term or transitional care.

Sep 19
4 min

Vizient and Surgery Exchange partner for a cloud-based solution for surgical process challenges

With this partnership, Vizient will be able to solve a historical challenge for managing inventory for implant surgeries.

Sep 18
3 min

Elevian closes on $40 million to advance treatments for age related diseases and stroke recovery

Elevian's novel approach could be transformational and bring hope to the millions of stroke victims around the world every year.

Sep 16
3 min

Vibrato Medical receives $4 million funding and $1.5 million NIH grant for trials of its PAD device

Our goal is to become the preferred therapeutic system for patients with reduced tissue perfusion, such as those with PAD and CLI.

Sep 14
6 min

Alebund Pharmaceuticls closes on $54.5 million to expand treatment for renal disease

Alebund Pha has built a diversified pipeline of drug candidates after three years of rapid growth, targeting a range of major renal diseases

Sep 13
3 min

Midwest Eye Consultants receives strategic investment to expand its services for eye care practices

Midwest Eye's provides optometry and ophthalmology practices with primary care, surgical services, LASIK and prescription eyewear.

Sep 12
4 min

Premier Inc. joins 11 health systems in investing in Exela Pharma Sciences to support US drug supply

Leveraging Exela’s production capacity, this collaboration is expected to give Premier’s members access to US manufactured drugs.

Sep 11
4 min

DotCom Therapy raises $13 million to advance solutions for the shortage of mental health workers

DotCom Therapy currently provides services for over 400 schools and health systems across 38 states.

Sep 10
3 min

HTL Biotechnology becomes the exclusive API manufacturer for Eirion Therapeutics

This agreement marks an expansion of HTL's biotechnology beyond its work in hyaluronic acid and bio-polymer manufacturing.

Sep 6
4 min

Genetic testing firm DnaNudge closes on $60 million to advance deploymnet of its rapid genetic tests

The game-changing nature of our innovation has created an extraordinary commercial opportunity within next-generation medical diagnostics.

Sep 4
1 min

Laplace Interventional closes on $7.9 million to advanc its transcatheter tricuspid valve technology

Laplace Interventional’s device aims to increase the life expectancy to patients with Tricuspid Regurgitation (TR).

Sep 3
2 min

Cellect Biotechnology (Nasdaq: APOP) announces its first US ApoGraft Bone Marrow Transplantation

Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue.

Sep 2
4 min

quip closes on $100 million to revolutionize oral healthcare, in the US and globally

“quip is well on its way to becoming the iconic oral care brand in the way we’ve seen companies revolutionize other industries."

Aug 31
4 min

The genetic testing pioneer DnaNudge completes $60 million financing to accelerate testing solutions

DnaNudge to accelerate global deployment of its genetic testing solutions including the first ever sample-to-result RT-PCR COVID-19 test,

Aug 31
4 min

Atavistik Bio closes $60 million for its drug discovery platform for metabolic diseases and cancer

Atavistik combines a platform with drug design capabilities and cutting-edge insights into the regulation of metabloic systems.

Aug 30
3 min

Checkpoint Surgical wraps up $16 million for sales expansion and new product development

Checkpoint works alongside surgeons to advance the science and practice of peripheral nerve care through research, and product development.

Aug 29
5 min

HealthCareRoyalty commits up to $325 million to ADC Therapeutics (NYSE:ADCT)

ZYNLONTA is a CD19-directed antibody drug conjugate. Once bound to a CD19-expressing cell, ZYNLONTA is internalized by the cell.

Aug 28
4 min

Medical device company Lazurite contracts with UH Ventures for its wireless surgical camera

The ArthroFree system is expected to be the world’s first FDA-approved wireless, minimally invasive camera system for the operating room.

Aug 27
3 min

Neurogastrx closes on $60 million to advance its pipeline of therapies for GI disorders

The financing will advance the company’s pipeline of GI therapies for conditions that impact millions but are not effecitvely treated.

Aug 26
2 min

Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq

Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management.

Aug 26
3 min

NRx Pharmaceuticals closes on $30 million to advance its drug for the sickest of COVID-19 patients

NRx Pharmaceuticals has more than 300 years of collective, scientific and drug-development experience to bring improved health to patients.

Aug 26
4 min

AllStripes raises $50 million to support research for 100 new rare diseases

“Beginning research on a rare condition can feel like being dropped into a new world without a map and we are on a mission to change that.."

Aug 25
4 min

Pre-clinical startup, Atavistik closes on $60 million for genetically validated targets in cancer...

The new financing will support development of Atavastik’s drug discovery platform.

Aug 24
3 min

Lazurite ramps up marketing for its ArthroFree wireless arthroscopic camera system

the ArthroFree system has compatibility with various flexible and rigid endoscopes, as well as surgical tower systems.

Aug 21
4 min

Omnicell (Nasdaq: OMCL) announces latest enhancements ot its medication managment solutions

Omnicell is optimizing the advanced hardware, software, and technology-enabled services that support a move toward the Autonomous Pharmacy.

Aug 20
4 min

ArchiveCore receives investment from the Center for Innovative Technology for credentialing

Today’s U.S healthcare systems spend roughly $5.5 billion on credentialing physicians each year. The process is outdated...

Aug 18
5 min

EpiEndo Pharmaceuticals closes on $23.4 million to advance its non-antibiotic macrolide for COPD

The financing secures funds to advance clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April

Aug 17
3 min

Healthcare cyber attack preventer CyberMax receives investment to accelerate growth and innovation

“CyberMaxx’s expertise positions them on the forefront of keeping our nation’s healthcare providers and their patients safe and secure."

Aug 15
2 min

MaxCyte signs license with Sana Biotechnology for its platform for hypoimmune cell therapy

MaxCyte's instrument portfolio represents the next generation of clinically-validated, electroporation technology for cell engineering

Aug 14
3 min

Fluid Biotech raises $4.7 million in seed financing for bioabsorbable stents to cure brain aneurysms

Fluid Biotech is commercializing the world's first hybrid polymer-metal flow-diverting brain stents to cure brain aneurysms.

Aug 13
3 min

GentBio closes $157 million funding to advance engineered regulatory T cells as therapeutics

GentiBio is an emerging biotherapeutics company developing engineered regulatory T cells programmed to treat diseases.

Aug 11
4 min

Intelligencia closes on $12 million for its AI-driven platform to revolutionize drug development

Intelligencia is an AI-driven technology company that focuses on minimizing the risk of drug development and enabling external innovation.

NEWS CATEGORIES (Click Below)

Artificial Intelligence
Business & Financial Transactions
Covid-19
Cannabinoid-Based Drug Develoment
Clinical Trials and Drug Development
Financings and Investment Transactions
Healthcare
Healthcare Technology
Medical Devices
Pharma, Biotech & Biopharma
Product, Devices, Services or Technology Launches
Psychedelics
Strategic Transactions
Telemedicine
Veterinary and Animal Health